Key result
Anticoagulation in pregnant women with mechanical heart valves lacks an ideal regimen, with current AHA/ACC guidelines providing class recommendations based on limited available evidence.
Why the study?
What is the optimal anticoagulation regimen for pregnant women with mechanical heart valves?
What is the optimal anticoagulation regimen for pregnant women with mechanical heart valves?
This review summarizes current evidence and AHA/ACC guidelines for managing anticoagulation in pregnant women with mechanical heart valves, highlighting the lack of an ideal regimen.
No ideal regimen exists for anticoagulation in pregnant women with mechanical valves; leaves open the need for higher-quality trials to inform guidelines.
The management of women with mechanical heart valves during pregnancy remains difficult and controversial. There is no ideal anticoagulation regimen for this unique population, as there are inherent risks and benefits of each approach for both mother and fetus. There has been limited data available to guide the clinician in the optimal treatment strategy for an individual patient. The AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease created class recommendations for this population based upon current evidence, which is summarized in this review.
No takes yet. Share an insight, caveat, or question.
Nishimura et al. (2015) conducted a review in Mechanical heart valves during pregnancy. Anticoagulation was evaluated. Anticoagulation in pregnant women with mechanical heart valves lacks an ideal regimen, with current AHA/ACC guidelines providing class recommendations based on limited available evidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: